Showing results (21-30 of 269) with videos related to
Sort By:
Pageof 27
Gut|September 16, 1999
Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failureP B Jeppesen, B Hartmann, B S Hansen, et al.The Journal of Clinical Endocrinology and Metabolism|August 18, 2000
In vivo and in vitro degradation of glucagon-like peptide-2 in humansB Hartmann, M B Harr, P B Jeppesen, et al.Gut|August 15, 2000
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colonP B Jeppesen, B Hartmann, J Thulesen, et al.Regulatory Peptides|November 20, 2012
Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patientsP Høyerup, P M Hellström, P T Schmidt, et al.European Journal of Clinical Nutrition|July 26, 2012
Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndromeP Lund, P T Sangild, L Aunsholt, et al.The Journal of Nutrition|November 11, 2003
Clinical significance of GLP-2 in short-bowel syndromeP B JeppesenDrugs of Today (Barcelona, Spain : 1998)|November 6, 2013
Teduglutide for the treatment of short bowel syndromeP B JeppesenRegulatory Peptides|March 21, 2013
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled studyK B Madsen, C Askov-Hansen, R M Naimi, et al.Regulatory Peptides|March 19, 2013
A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patientsR M Naimi, K B Madsen, C Askov-Hansen, et al.Gastroenterology Research and Practice|July 11, 2009
Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of lifeP B Jeppesen, P Lund, I B Gottschalck, et al.Pageof 27